Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 15, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 16, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001140536-26-000013
Filed / recorded
Jan 16, 2026, 10:34 PM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
WILLIS TOWERS WATSON PLC
Issuer CIK
1140536
Ticker
WTW
Reporting person
Julie Jarecke Gebauer
Relationship
Officer
Officer title
Pres.-Health, Wealth & Career
Security
Ordinary Shares, nominal value $0.000304635 per share
Table
Non-derivative (Table I)
Transaction date
Jan 15, 2026
Transaction code
A
Shares / units
8.885
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
71,622.353
Ownership form
Direct
Amendment
No
Footnotes from the filing
The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.
A board member of Willis Towers Watson paid $67K out of pocket for Willis Towers Watson shares. 1 other person at Willis Towers Watson bought some too, in the same month. The Willis Towers Watson shares held grew by 11%.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.